EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Examining the Use of Serum Biomarkers to Guide Early Detection of Pancreatic Cancer

Christina Zhang

Clinical Journal of Oncology Nursing · 2025

DOI: 10.1188/25.cjon.151-156 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Journal of Oncology Nursing, 2025. Verfasst von Christina Zhang. Beteiligte Einrichtung: Christina Zhang. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Carcinoma, Pancreatic Ductal, Early Detection of Cancer, Pancreatic Neoplasms. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatic cancer is estimated to become the second leading cause of cancer-related death by 2030 because of high malignancy, late diagnosis, inefficient therapy, and a lack of available screening for early detection. OBJECTIVES: This article presents current clinical data supporting the use of serum biomarker signatures as a modality for early pancreatic ductal adenocarcinoma (PDAC) diagnosis and treatment. METHODS: A clinical case study highlights the use of serum biomarker signatures in PDAC diagnosis. Clinical guidelines on PDAC were obtained from the National Comprehensive Cancer Network, the National Cancer Institute, StatPearls Publishing, the American Cancer Society, and the Pancreatic Cancer Detection Consortium. FINDINGS: Screening barriers involve a low incidence and histologic heterogeneity of disease, as well as a need for prospective multicenter analysis of proposed biomarkers. Because the poor prognosis of PDAC is attributed to late detection, the development of a clinical guideline for biomarker-based screening warrants interprofessional awareness and advocacy in oncology clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorCarcinoma, Pancreatic DuctalEarly Detection of CancerPancreatic NeoplasmsAgedHumansMalePractice Guidelines as Topic

Stichwörter der Autor:innen

biomarker signaturespancreatic ductal adenocarcinomatime to treatment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Christina Zhang.

Zitieren

APA

Zhang, C. (2025). Examining the Use of Serum Biomarkers to Guide Early Detection of Pancreatic Cancer. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/25.cjon.151-156

Vancouver

Zhang C. Examining the Use of Serum Biomarkers to Guide Early Detection of Pancreatic Cancer. Clinical Journal of Oncology Nursing. 2025. doi:10.1188/25.cjon.151-156

BibTeX
@article{Zhang2025,
  author = {Zhang, Christina},
  title = {Examining the Use of Serum Biomarkers to Guide Early Detection of Pancreatic Cancer},
  journal = {Clinical Journal of Oncology Nursing},
  year = {2025},
  doi = {10.1188/25.cjon.151-156}
}
Kostenlos starten →